RNA interference in the clinic: challenges and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNA interference in the clinic: challenges and future directions

Published:2010-12-16 Issue:1 Volume:11 Page:59-67
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Pecot Chad V.,Calin George A.,Coleman Robert L.,Lopez-Berestein Gabriel,Sood Anil K.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc2966.pdf

Reference99 articles.

1. Fire, A. et al. Potent and specific genetic interference by double-strandedRNA in Caenorhabditis elegans. Nature 391, 806–811 (1998).

2. Druker, B. J. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355, 2408–2417 (2006).

3. Smith, I. et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369, 29–36 (2007).

4. Kikani, C. K., Dong, L. Q. & Liu, F. “New”-clear functions of PDK1: beyond a master kinase in the cytosol? J. Cell. Biochem. 96, 1157–1162 (2005).

5. Lim, S. T., Mikolon, D., Stupack, D. G. & Schlaepfer, D. D. FERM control of FAK function: implications for cancer therapy. Cell Cycle 7, 2306–2314 (2008).

Cited by 710 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nanotherapeutic strategies for Huntington's disease: Design, delivery, and neuroprotective mechanisms;Coordination Chemistry Reviews;2025-01

2. MicroRNA-135b mainly functions as an oncogene during tumor progression;Pathology - Research and Practice;2024-10

3. Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential;Biomedicine & Pharmacotherapy;2024-10

4. A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem;Advanced Science;2024-08-29

5. The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy;Advanced Healthcare Materials;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3